Ilkos Therapeutics


Public lists: Pharma Startups (6570)

Ilkos Therapeutics is a Quebec biotechnology firm tasked with the development of S42909, a compound indicated in the treatment of venous lower limb ulcers. The target indication is the oral treatment of venous lower limb ulcers, a disease that affects 1% to 1.5% of the population, mainly older people. Current treatment, which besides being only moderately effective for complete wound healing and limited to compression bandages and local wound care, is labour intensive, accounting for 1.5% to 2% ...Show all

Ilkos Therapeutics is a Quebec biotechnology firm tasked with the development of S42909, a compound indicated in the treatment of venous lower limb ulcers. The target indication is the oral treatment of venous lower limb ulcers, a disease that affect...Show all

Company (Alive / Active)

Phone:

Fax:



Montreal,
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ilkos Therapeutics $15.9M Sep 26, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ilkos Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)